Search research articles
Contact Us
Filters
Showing results (181-190 of 332) with videos related to
Page
of 34
Sort By:
NPJ Digital Medicine
|
March 24, 2023
Weakly supervised deep learning to predict recurrence in low-grade endometrial cancer from multiplexed immunofluorescence images
Daniel Jiménez-Sánchez, Álvaro López-Janeiro, María Villalba-Esparza, et al.
Immunobiology
|
June 22, 2026
Monomethyl-auristatin E-based anti-CD137 (4-1BB) antibody drug conjugates are not suitable tools to deplete activated T lymphocytes
Gabriel Gomis, Saioa Arrieta-Aranzueque, Claudia Herrero, et al.
European Journal of Immunology
|
January 18, 2008
IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis
Ivan Martinez-Forero, Ricardo Garcia-Munoz, Sara Martinez-Pasamar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma
Oihana Murillo, Ainhoa Arina, Sandra Hervas-Stubbs, et al.
Plos One
|
January 4, 2013
Liver gene transfer of interkeukin-15 constructs that become part of circulating high density lipoproteins for immunotherapy
Maria C Ochoa, Jessica Fioravanti, Erwin H Duitman, et al.
BMJ Oncology
|
February 25, 2026
First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours
Carlos Gomez-Roca, Stéphane Champiat, Francois-Xavier Danlos, et al.
EMBO Molecular Medicine
|
November 21, 2019
Repurposing the yellow fever vaccine for intratumoral immunotherapy
Maria Angela Aznar, Carmen Molina, Alvaro Teijeira, et al.
Cancer Discovery
|
October 24, 2015
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Alfonso R Sánchez-Paulete, Francisco J Cueto, María Martínez-López, et al.
Oncoimmunology
|
January 4, 2018
Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB)
Arantza Azpilikueta, Elixabet Bolaños, Valerie Lang, et al.
Journal for Immunotherapy of Cancer
|
January 16, 2026
Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors
Ignacio Melero, Neeltje Steeghs, Ulrik Lassen, et al.
Page
of 34
Search research articles
Search
Showing results (181-190 of 332) with videos related to
Sort By:
Page
of 34
NPJ Digital Medicine
|
March 24, 2023
Weakly supervised deep learning to predict recurrence in low-grade endometrial cancer from multiplexed immunofluorescence images
Daniel Jiménez-Sánchez, Álvaro López-Janeiro, María Villalba-Esparza, et al.
Immunobiology
|
June 22, 2026
Monomethyl-auristatin E-based anti-CD137 (4-1BB) antibody drug conjugates are not suitable tools to deplete activated T lymphocytes
Gabriel Gomis, Saioa Arrieta-Aranzueque, Claudia Herrero, et al.
European Journal of Immunology
|
January 18, 2008
IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis
Ivan Martinez-Forero, Ricardo Garcia-Munoz, Sara Martinez-Pasamar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma
Oihana Murillo, Ainhoa Arina, Sandra Hervas-Stubbs, et al.
Plos One
|
January 4, 2013
Liver gene transfer of interkeukin-15 constructs that become part of circulating high density lipoproteins for immunotherapy
Maria C Ochoa, Jessica Fioravanti, Erwin H Duitman, et al.
BMJ Oncology
|
February 25, 2026
First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours
Carlos Gomez-Roca, Stéphane Champiat, Francois-Xavier Danlos, et al.
EMBO Molecular Medicine
|
November 21, 2019
Repurposing the yellow fever vaccine for intratumoral immunotherapy
Maria Angela Aznar, Carmen Molina, Alvaro Teijeira, et al.
Cancer Discovery
|
October 24, 2015
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Alfonso R Sánchez-Paulete, Francisco J Cueto, María Martínez-López, et al.
Oncoimmunology
|
January 4, 2018
Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB)
Arantza Azpilikueta, Elixabet Bolaños, Valerie Lang, et al.
Journal for Immunotherapy of Cancer
|
January 16, 2026
Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors
Ignacio Melero, Neeltje Steeghs, Ulrik Lassen, et al.
Page
of 34